The Veterinary Clostridium Vaccine Market is anticipated to grow at a CAGR of 15.5% during the above forecast period (2022-2027).
That Veterinary Clostridium vaccines market research provides an in-depth analysis of the entire market. Global Veterinary Clostridium Vaccines Market research report covers specific segments such as opportunities, size, development, innovation, sales, and overall growth of leading players. The research is based on primary and secondary statistical sources and includes both qualitative and quantitative information. In this report, professionals offer the readers unbiased perspectives of the global Veterinary Clostridium Vaccines Market to help them make informed business decisions.
Get a sample copy of this report:
Some of the major players profiled in the report are Elanco, CanFel Therapeutics, Merck, Zoetis, Advaxis, Merial, ARKO Labs, MPLIPHI, Bayer, Aratana Therapeutics, NEXVET, Valneva SE, Nuovo Biologics, Ceva, Genus, Epitopix, Virbac, Hygieia Biological Laboratories, Colorado Serum Company, Vetoquinol and others .
Market overview:
The global veterinary Clostridium vaccine market is expected to grow due to a variety of factors including an increase in clostridial disease, an increase in clostridial disease infection and an increase in livestock. The high mortality rates from Clostridial diseases, the increasing demand for meat and other animal products, the use of animals in agriculture, the accessibility and affordability of treatment options, the growing public interest in animal welfare, the expansion of government programs and the rise in pet adoption are other contributing factors. In 2016, there were 92 million cattle in the United States, and a significant portion of that herd was…
[ad_2]
Source story
